Epirubicin is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC soft tissue and bone sarcoma group

Author： Nielsen Ole S.   Mouridsen Henning   Daugaard Soren   Verweij Jaap   Dombernowsky Per   Van Glabbeke Martine   Kirkpatrick Anne  

Publisher： Informa Healthcare

ISSN： 1369-1643

Source： Sarcoma, Vol.4, Iss.1-2, 2000-03, pp. : 31-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

By Svancarova L.   Blay J.Y.   Judson I.R.   van Hoesel Q.G.C.M.   van Oosterom A.T.   le Cesne A.   Keizer H.J.   Hermans C.   van Glabbeke M.   Verweij J.   Hogendoorn P.C.W.   Nielsen O.S.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 556-559

Elsevier

Access to resources Recommend Favorite

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL(R)/CAELYX(R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma - a study by the EORTC Soft Tissue and Bone Sarcoma Group

By Judson I.   Radford J.A.   Harris M.   Blay J.-Y.   van Hoesel Q.   le Cesne A.   van Oosterom A.T.   Clemons M.J.   Kamby C.   Hermans C.   Whittaker J.   Donato di Paola E.   Verweij J.   Nielsen S.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 870-877

Elsevier

Access to resources Recommend Favorite

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group - is it feasible?

By Nielsen O.S.   Judson I.   van Hoesel Q.   le Cesne A.   Keizer H.J.   Blay J.Y.   van Oosterom A.   Radford J.A.   Svancarova L.   Krzemienlecki K.   Hermans C.   van Glabbeke M.   Oosterhuis J.W.   Verweij J.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 61-67

Elsevier

Access to resources Recommend Favorite

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

By Woll P.J.   Judson I.   Lee S.M.   Rodenhuis S.   Nielsen O.S.   Buesa J.M.   Lorigan P.C.   Leyvraz S.   Hermans C.   van Glabbeke M.   Verweij J.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 410-412

Elsevier

Access to resources Recommend Favorite

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients

By van Oosterom A.T.   Mouridsen H.T.   Nielsen O.S.   Dombernowsky P.   Krzemieniecki K.   Judson I.   Svancarova L.   Spooner D.   Hermans C.   Van Glabbeke M.   Verweij J.   for the EORTC STBSG  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2397-2406

Elsevier

Access to resources Recommend Favorite